Pharmaceutical company AstraZeneca has announced that a manufacturing error has caused what may be a fortunate discovery in regards to the COVID-19 vaccine they are producing, in that the drug may be much more effective at lower doses than anticipated. The Oxford University-developed inoculant is amongst a host of vaccine candidates thatread more

A large-scale clinical trial conducted by the World Health Organization has determined that Gilead Sciences Inc.’s remdesivir had little or no effect on COVID-19 patients’ chances of survival or length of hospital stay. The antiviral drug had been granted Emergency Use Authorization (EUA) by the Food and Drug Administration inread more